The health, safety and well-being of our residents, visitors and staff is Coate Water Care’s number one priority and our very high standards in safety and cleanliness provide peace of mind to both residents and their loved ones.

  • All visitors are screened for symptoms of COVID-19
  • Plentiful stocks of full PPE
  • Social distancing in place
  • Enhanced cleaning procedures
  • Latest care sector technology tracks residents’ health
  • Staff trained in infection control and PPE use


All residents have been offered Covid Vaccinations and boosters. Staff at all nine Coate Water Care homes have had their COVID-19 vaccinations, or are medically exempt and our homes are a safe environment for new residents.

Visiting our homes

Our homes are open for visitors, and we have a booking system in place at each home. Check with your local home to find out the latest arrangements, and to book a visit.

CQC inspections

The CQC has been carrying out special inspections to make sure our care homes are COVID-compliant. There are no ratings for these inspections but our good safety practices have been acknowledged.

Latest News.

15 January 2020

Vaccine for dementia to enter human trials after successful tests on mice

A vaccine designed to prevent dementia is to enter human trials after successful tests on mice.

If the treatment is proven to work safely on people it could be available within a decade, researchers say.

The revelation, published in the journal Alzheimer’s Research & Therapy, comes after 20 years of research backed by the US government and largely carried out in Australia.

The treatment – a combination of two different drugs – is said to work by targeting and then removing the brain plaque and nanofibre tangles which lead to cognitive decline and memory failure.

It also has the potential to prevent Alzheimer’s in people who are predisposed to the disease, researchers say.
It is said to be unlike anything currently available, because the most medicines have achieved so far is to reduce symptoms rather than targeting the specific problems affecting the brain.
Stock image

Professor Nikolai Petrovsky, a specialist in endocrinology at Flinders University in Adelaide, where much of the work is being carried out, said: “This vaccine could be revolutionary. It’s not something that will be available tomorrow, but it’s an exciting step in the right direction.”

He told Australia’s Daily Telegraph: “This is not the start of the journey, it’s the end.”

And he added he was now optimistic human trials will have started within 20 months.

However, there may be reason for caution, as several promising drugs said to help with dementia have previously failed clinical trials.
Colin Drury - The Independent

Download a copy of one of our home brochures.

I accept the terms and conditions